195 related articles for article (PubMed ID: 30852974)
1. Prognostic nomogram for patients with non-metastatic HER2 positive breast cancer in a prospective cohort.
Luo C; Zhong X; Wang Z; Wang Y; Wang Y; He P; Peng Q; Zheng H
Int J Biol Markers; 2019 Mar; 34(1):41-46. PubMed ID: 30852974
[TBL] [Abstract][Full Text] [Related]
2. Establishment of Prognostic Nomograms for Predicting the Survival of HR-Positive, HER2-Negative Metastatic Breast Cancer Patients Treated with Everolimus.
Duan F; Song C; Ma Y; Jiang K; Xu F; Bi X; Huang J; Hong R; Huang Z; Lu Q; Yuan Z; Wang S; Xia W
Drug Des Devel Ther; 2021; 15():3463-3473. PubMed ID: 34408400
[TBL] [Abstract][Full Text] [Related]
3. Development and validation of nomogram combining serum biomarker for predicting survival in patients with resected rectal cancer.
Fan S; Li T; Zhou P; Peng Q; Zhu Y
Biosci Rep; 2019 Nov; 39(11):. PubMed ID: 31693739
[TBL] [Abstract][Full Text] [Related]
4. Prognostic factors and survival prediction in HER2-positive breast cancer with bone metastases: A retrospective cohort study.
Lyu X; Luo B
Cancer Med; 2021 Nov; 10(22):8114-8126. PubMed ID: 34612593
[TBL] [Abstract][Full Text] [Related]
5. Nomogram-Predicted Survival of Breast Cancer Brain Metastasis: a SEER-Based Population Study.
Xiong Y; Cao H; Zhang Y; Pan Z; Dong S; Wang G; Wang F; Li X
World Neurosurg; 2019 Aug; 128():e823-e834. PubMed ID: 31096027
[TBL] [Abstract][Full Text] [Related]
6. Prognostic nomogram for female patients suffering from non-metastatic Her2 positive breast cancer: A SEER-based study.
Wu J; Xie Z; Xiao Y; Wang B; Zhang P
Medicine (Baltimore); 2022 Oct; 101(40):e30922. PubMed ID: 36221419
[TBL] [Abstract][Full Text] [Related]
7. Establishing a predicted model to evaluate prognosis for initially diagnosed metastatic Her2-positive breast cancer patients and exploring the benefit from local surgery.
Lin H; Wu Y; Liang G; Chen L
PLoS One; 2020; 15(11):e0242155. PubMed ID: 33170907
[TBL] [Abstract][Full Text] [Related]
8. Development and validation of a prognostic nomogram based on the log odds of positive lymph nodes (LODDS) for breast cancer.
Wen J; Ye F; He X; Li S; Huang X; Xiao X; Xie X
Oncotarget; 2016 Apr; 7(15):21046-53. PubMed ID: 26992235
[TBL] [Abstract][Full Text] [Related]
9. Construction and validation of a nomogram to predict overall survival in patients with inflammatory breast cancer.
Diao JD; Ma LX; Sun MY; Wu CJ; Wang LJ; Liu YL; Yang YJ
Cancer Med; 2019 Sep; 8(12):5600-5608. PubMed ID: 31407527
[TBL] [Abstract][Full Text] [Related]
10. A Novel Nomogram and Risk Classification System Predicting the Cancer-Specific Survival of Patients with Initially Diagnosed Metastatic Esophageal Cancer: A SEER-Based Study.
Tang X; Zhou X; Li Y; Tian X; Wang Y; Huang M; Ren L; Zhou L; Ding Z; Zhu J; Xu Y; Peng F; Wang J; Lu Y; Gong Y
Ann Surg Oncol; 2019 Feb; 26(2):321-328. PubMed ID: 30357578
[TBL] [Abstract][Full Text] [Related]
11. Development and validation of a nomogram predicting the overall survival of stage IV breast cancer patients.
Li S; Zhao J; Zhu L; Su F; Chen K
Cancer Med; 2017 Nov; 6(11):2586-2594. PubMed ID: 28980424
[TBL] [Abstract][Full Text] [Related]
12. Validation of CTS5 Model in Large-scale Breast Cancer Population and Combination of CTS5 and Ki-67 Status to Develop a Novel Nomogram for Prognosis Prediction.
Ning L; Liu Y; He X; Han R; Xin Y; Zhao J; Liu X
Am J Clin Oncol; 2024 May; 47(5):228-238. PubMed ID: 38131531
[TBL] [Abstract][Full Text] [Related]
13. Construction and validation of nomogram for the cancer-specific mortality for HER2-positive breast cancer patients.
Wu N
Medicine (Baltimore); 2024 Mar; 103(11):e37330. PubMed ID: 38489717
[TBL] [Abstract][Full Text] [Related]
14. Prognostic nomogram for previously untreated patients with esophageal squamous cell carcinoma after esophagectomy followed by adjuvant chemotherapy.
Duan J; Deng T; Ying G; Huang D; Zhang H; Zhou L; Bai M; Li H; Yang H; Qu Y; Wang X; Ba Y
Jpn J Clin Oncol; 2016 Apr; 46(4):336-43. PubMed ID: 26819278
[TBL] [Abstract][Full Text] [Related]
15. Individualized Prediction of Survival Benefit from Postmastectomy Radiotherapy for Patients with Breast Cancer with One to Three Positive Axillary Lymph Nodes.
Zhang N; Zhang J; Zhang H; Liu Y; Zhao W; Wang L; Chen B; Moran MS; Haffty BG; Yang Q
Oncologist; 2019 Dec; 24(12):e1286-e1293. PubMed ID: 31315963
[TBL] [Abstract][Full Text] [Related]
16. A nomogram for predicting survival in patients with de novo metastatic breast cancer: a population-based study.
Zhao W; Wu L; Zhao A; Zhang M; Tian Q; Shen Y; Wang F; Wang B; Wang L; Chen L; Zhao X; Dong D; Zhang L; Yang J
BMC Cancer; 2020 Oct; 20(1):982. PubMed ID: 33046035
[TBL] [Abstract][Full Text] [Related]
17. Nomograms predict survival of patients with lymph node-positive, luminal a breast cancer.
Li Y; Ma L
BMC Cancer; 2021 Aug; 21(1):965. PubMed ID: 34454451
[TBL] [Abstract][Full Text] [Related]
18. Development and validation of a nomogram to predict overall survival for patients with metastatic renal cell carcinoma.
Zheng W; Zhu W; Yu S; Li K; Ding Y; Wu Q; Tang Q; Zhao Q; Lu C; Guo C
BMC Cancer; 2020 Nov; 20(1):1066. PubMed ID: 33148204
[TBL] [Abstract][Full Text] [Related]
19. Development and validation of a prognostic nomogram for early HER2-positive and lymph node-negative breast cancer.
Shi Q; Wang J; Ai X; Xuhong J; Ma D; Zhang Y; Qi X; Jiang J
Gland Surg; 2021 Jul; 10(7):2255-2265. PubMed ID: 34422596
[TBL] [Abstract][Full Text] [Related]
20. A nomogram for predicting breast cancer specific survival in elderly patients with breast cancer: a SEER population-based analysis.
Yang R; Wu Y; Qi Y; Liu W; Huang Y; Zhao X; Chen R; He T; Zhong X; Li Q; Zhou L; Chen J
BMC Geriatr; 2023 Sep; 23(1):594. PubMed ID: 37749538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
